Trevena (TRVN) Competitors $1.75 +0.07 (+4.17%) (As of 12:15 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TRVN vs. VCNX, AIMD, VRAX, VIRX, CDIO, HOTH, HURA, ONVO, AEZS, and BMRAShould you be buying Trevena stock or one of its competitors? The main competitors of Trevena include Vaccinex (VCNX), Ainos (AIMD), Virax Biolabs Group (VRAX), Viracta Therapeutics (VIRX), Cardio Diagnostics (CDIO), Hoth Therapeutics (HOTH), TuHURA Biosciences (HURA), Organovo (ONVO), Aeterna Zentaris (AEZS), and Biomerica (BMRA). These companies are all part of the "pharmaceutical products" industry. Trevena vs. Vaccinex Ainos Virax Biolabs Group Viracta Therapeutics Cardio Diagnostics Hoth Therapeutics TuHURA Biosciences Organovo Aeterna Zentaris Biomerica Vaccinex (NASDAQ:VCNX) and Trevena (NASDAQ:TRVN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, community ranking, profitability and media sentiment. Which has more volatility and risk, VCNX or TRVN? Vaccinex has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500. Comparatively, Trevena has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. Does the MarketBeat Community favor VCNX or TRVN? Trevena received 493 more outperform votes than Vaccinex when rated by MarketBeat users. Likewise, 70.00% of users gave Trevena an outperform vote while only 60.00% of users gave Vaccinex an outperform vote. CompanyUnderperformOutperformVaccinexOutperform Votes12360.00% Underperform Votes8240.00% TrevenaOutperform Votes61670.00% Underperform Votes26430.00% Is VCNX or TRVN more profitable? Company Net Margins Return on Equity Return on Assets VaccinexN/A N/A -383.58% Trevena N/A N/A -119.55% Do insiders and institutionals have more ownership in VCNX or TRVN? 50.1% of Vaccinex shares are held by institutional investors. Comparatively, 13.6% of Trevena shares are held by institutional investors. 51.5% of Vaccinex shares are held by insiders. Comparatively, 2.7% of Trevena shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media favor VCNX or TRVN? In the previous week, Trevena had 10 more articles in the media than Vaccinex. MarketBeat recorded 12 mentions for Trevena and 2 mentions for Vaccinex. Vaccinex's average media sentiment score of 0.67 beat Trevena's score of 0.61 indicating that Vaccinex is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vaccinex 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Trevena 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, VCNX or TRVN? Vaccinex has higher earnings, but lower revenue than Trevena. Vaccinex is trading at a lower price-to-earnings ratio than Trevena, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaccinex$570K10.56-$20.25M-$48.27-0.07Trevena$3.12M0.48-$40.29M-$47.04-0.04 Do analysts recommend VCNX or TRVN? Trevena has a consensus price target of $5.00, suggesting a potential upside of 185.71%. Given Trevena's stronger consensus rating and higher probable upside, analysts plainly believe Trevena is more favorable than Vaccinex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vaccinex 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Trevena 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryTrevena beats Vaccinex on 10 of the 15 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get Trevena News Delivered to You Automatically Sign up to receive the latest news and ratings for TRVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRVN vs. The Competition Export to ExcelMetricTrevenaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.51M$6.49B$5.09B$8.79BDividend YieldN/A8.11%5.04%4.07%P/E Ratio-0.045.3293.0914.02Price / Sales0.48370.921,220.6787.41Price / CashN/A52.5939.4936.27Price / Book-0.0610.236.936.33Net Income-$40.29M$153.22M$118.83M$225.71M7 Day Performance3.55%-1.99%-1.74%-0.58%1 Month Performance-8.85%-7.51%-3.60%1.49%1 Year Performance-87.93%31.02%31.91%27.23% Trevena Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRVNTrevena1.396 of 5 stars$1.75+4.2%$5.00+185.7%-88.8%$1.51M$3.12M-0.0440Analyst ForecastAnalyst RevisionGap UpVCNXVaccinex0.5938 of 5 stars$3.48-6.2%N/A-70.2%$6.02M$570,000.00-0.0740AIMDAinos0.6806 of 5 stars$0.43+0.4%N/A-86.2%$5.98M$120,000.000.0046Gap DownVRAXVirax Biolabs Group0.2701 of 5 stars$1.85-1.9%N/A-24.8%$5.96M$160,000.000.005VIRXViracta Therapeutics1.5718 of 5 stars$0.15-1.8%$5.00+3,253.5%-72.4%$5.93MN/A0.0020Analyst RevisionGap DownCDIOCardio Diagnostics2.1281 of 5 stars$0.25+0.6%$2.00+714.3%-89.0%$5.88M$20,000.000.007HOTHHoth Therapeutics2.3345 of 5 stars$0.85+2.3%$3.50+313.7%-22.0%$5.84MN/A-0.634News CoverageHURATuHURA Biosciences0.9613 of 5 stars$3.39+3.0%$15.00+342.5%N/A$5.39MN/A0.00N/ANegative NewsGap UpONVOOrganovo0.6793 of 5 stars$0.35flatN/A-72.7%$5.38M$110,000.00-0.3320Analyst ForecastNews CoverageAEZSAeterna ZentarisN/A$2.98-0.7%N/A-57.4%$5.35M$2.37M-0.2020BMRABiomerica0.2078 of 5 stars$0.31-4.2%N/A-64.4%$5.23M$5.41M-0.8860News CoverageGap Down Related Companies and Tools Related Companies VCNX Alternatives AIMD Alternatives VRAX Alternatives VIRX Alternatives CDIO Alternatives HOTH Alternatives HURA Alternatives ONVO Alternatives AEZS Alternatives BMRA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TRVN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevena, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevena With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRVN Stock Alerts